ID   CHD1_YEAST              Reviewed;        1468 AA.
AC   P32657; D3DM72;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   18-JUN-2025, entry version 230.
DE   RecName: Full=Chromo domain-containing protein 1;
DE            EC=3.6.4.- {ECO:0000269|PubMed:10811623, ECO:0000269|PubMed:17949749};
DE   AltName: Full=ATP-dependent helicase CHD1;
GN   Name=CHD1; OrderedLocusNames=YER164W; ORFNames=SYGP-ORF4;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169868; DOI=10.1038/387s078;
RA   Dietrich F.S., Mulligan J.T., Hennessy K.M., Yelton M.A., Allen E.,
RA   Araujo R., Aviles E., Berno A., Brennan T., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Guzman E., Hartzell G., Hunicke-Smith S.,
RA   Hyman R.W., Kayser A., Komp C., Lashkari D., Lew H., Lin D., Mosedale D.,
RA   Nakahara K., Namath A., Norgren R., Oefner P., Oh C., Petel F.X.,
RA   Roberts D., Sehl P., Schramm S., Shogren T., Smith V., Taylor P., Wei Y.,
RA   Botstein D., Davis R.W.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome V.";
RL   Nature 387:78-81(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=9326634; DOI=10.1073/pnas.94.21.11472;
RA   Woodage T., Basrai M.A., Baxevanis A.D., Hieter P., Collins F.S.;
RT   "Characterization of the CHD family of proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:11472-11477(1997).
RN   [4]
RP   FUNCTION IN HISTONE ACETYLATION AT THE SAGA COMPLEX.
RX   PubMed=10026213; DOI=10.1074/jbc.274.9.5895;
RA   Grant P.A., Eberharter A., John S., Cook R.G., Turner B.M., Workman J.L.;
RT   "Expanded lysine acetylation specificity of Gcn5 in native complexes.";
RL   J. Biol. Chem. 274:5895-5900(1999).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10811623; DOI=10.1093/emboj/19.10.2323;
RA   Tran H.G., Steger D.J., Iyer V.R., Johnson A.D.;
RT   "The chromo domain protein chd1p from budding yeast is an ATP-dependent
RT   chromatin-modifying factor.";
RL   EMBO J. 19:2323-2331(2000).
RN   [6]
RP   INTERACTION WITH POB3 AND SPT16.
RX   PubMed=12242279; DOI=10.1128/mcb.22.20.6979-6992.2002;
RA   Krogan N.J., Kim M., Ahn S.H., Zhong G., Kobor M.S., Cagney G., Emili A.,
RA   Shilatifard A., Buratowski S., Greenblatt J.F.;
RT   "RNA polymerase II elongation factors of Saccharomyces cerevisiae: a
RT   targeted proteomics approach.";
RL   Mol. Cell. Biol. 22:6979-6992(2002).
RN   [7]
RP   IDENTIFICATION IN THE SLIK COMPLEX.
RX   PubMed=12446794; DOI=10.1128/mcb.22.24.8774-8786.2002;
RA   Pray-Grant M.G., Schieltz D., McMahon S.J., Wood J.M., Kennedy E.L.,
RA   Cook R.G., Workman J.L., Yates J.R. III, Grant P.A.;
RT   "The novel SLIK histone acetyltransferase complex functions in the yeast
RT   retrograde response pathway.";
RL   Mol. Cell. Biol. 22:8774-8786(2002).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RTF1 AND SPT5.
RX   PubMed=12682017; DOI=10.1093/emboj/cdg179;
RA   Simic R., Lindstrom D.L., Tran H.G., Roinick K.L., Costa P.J.,
RA   Johnson A.D., Hartzog G.A., Arndt K.M.;
RT   "Chromatin remodeling protein Chd1 interacts with transcription elongation
RT   factors and localizes to transcribed genes.";
RL   EMBO J. 22:1846-1856(2003).
RN   [9]
RP   FUNCTION.
RX   PubMed=14585955; DOI=10.1128/mcb.23.22.7937-7946.2003;
RA   Robinson K.M., Schultz M.C.;
RT   "Replication-independent assembly of nucleosome arrays in a novel yeast
RT   chromatin reconstitution system involves antisilencing factor Asf1p and
RT   chromodomain protein Chd1p.";
RL   Mol. Cell. Biol. 23:7937-7946(2003).
RN   [10]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [11]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-1144, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=SUB592;
RX   PubMed=12872131; DOI=10.1038/nbt849;
RA   Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G.,
RA   Roelofs J., Finley D., Gygi S.P.;
RT   "A proteomics approach to understanding protein ubiquitination.";
RL   Nat. Biotechnol. 21:921-926(2003).
RN   [12]
RP   IDENTIFICATION IN THE SAGA COMPLEX, IDENTIFICATION IN THE SLIK COMPLEX,
RP   FUNCTION IN SUBSTRATE RECOGNITION OF THE SLIK COMPLEX, INTERACTION WITH
RP   HISTONE H3, AND MUTAGENESIS OF GLU-220; HIS-222; LEU-314 AND TYR-316.
RX   PubMed=15647753; DOI=10.1038/nature03242;
RA   Pray-Grant M.G., Daniel J.A., Schieltz D., Yates J.R. III, Grant P.A.;
RT   "Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-
RT   dependent acetylation.";
RL   Nature 433:434-438(2005).
RN   [13]
RP   FUNCTION.
RX   PubMed=16606615; DOI=10.1074/jbc.m600682200;
RA   Stockdale C., Flaus A., Ferreira H., Owen-Hughes T.;
RT   "Analysis of nucleosome repositioning by yeast ISWI and Chd1 chromatin
RT   remodeling complexes.";
RL   J. Biol. Chem. 281:16279-16288(2006).
RN   [14]
RP   FUNCTION.
RX   PubMed=16468993; DOI=10.1111/j.1365-2958.2005.05031.x;
RA   Xella B., Goding C., Agricola E., Di Mauro E., Caserta M.;
RT   "The ISWI and CHD1 chromatin remodelling activities influence ADH2
RT   expression and chromatin organization.";
RL   Mol. Microbiol. 59:1531-1541(2006).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17949749; DOI=10.1016/j.jmb.2007.09.059;
RA   Ferreira H., Flaus A., Owen-Hughes T.;
RT   "Histone modifications influence the action of Snf2 family remodelling
RT   enzymes by different mechanisms.";
RL   J. Mol. Biol. 374:563-579(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [17]
RP   INTERACTION WITH RTF1.
RX   PubMed=17576814; DOI=10.1128/mcb.00772-07;
RA   Warner M.H., Roinick K.L., Arndt K.M.;
RT   "Rtf1 is a multifunctional component of the Paf1 complex that regulates
RT   gene expression by directing cotranscriptional histone modification.";
RL   Mol. Cell. Biol. 27:6103-6115(2007).
RN   [18]
RP   FUNCTION.
RX   PubMed=17620414; DOI=10.1128/mcb.00978-07;
RA   Biswas D., Dutta-Biswas R., Stillman D.J.;
RT   "Chd1 and yFACT act in opposition in regulating transcription.";
RL   Mol. Cell. Biol. 27:6279-6287(2007).
RN   [19]
RP   ASSOCIATION WITH RDNA, AND FUNCTION.
RX   PubMed=17259992; DOI=10.1038/nsmb1199;
RA   Jones H.S., Kawauchi J., Braglia P., Alen C.M., Kent N.A., Proudfoot N.J.;
RT   "RNA polymerase I in yeast transcribes dynamic nucleosomal rDNA.";
RL   Nat. Struct. Mol. Biol. 14:123-130(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17287358; DOI=10.1073/pnas.0607084104;
RA   Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L.,
RA   Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.;
RT   "Analysis of phosphorylation sites on proteins from Saccharomyces
RT   cerevisiae by electron transfer dissociation (ETD) mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007).
RN   [21]
RP   FUNCTION.
RX   PubMed=18245327; DOI=10.1534/genetics.107.084202;
RA   Biswas D., Takahata S., Xin H., Dutta-Biswas R., Yu Y., Formosa T.,
RA   Stillman D.J.;
RT   "A role for Chd1 and Set2 in negatively regulating DNA replication in
RT   Saccharomyces cerevisiae.";
RL   Genetics 178:649-659(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-987; SER-989;
RP   SER-1336 AND SER-1372, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-72; SER-987; SER-989
RP   AND SER-1336, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   3D-STRUCTURE MODELING OF THE SAGA COMPLEX.
RX   PubMed=15260971; DOI=10.1016/j.molcel.2004.06.005;
RA   Wu P.Y., Ruhlmann C., Winston F., Schultz P.;
RT   "Molecular architecture of the S. cerevisiae SAGA complex.";
RL   Mol. Cell 15:199-208(2004).
RN   [26]
RP   STRUCTURE BY NMR OF 172-252, AND DOMAIN.
RX   PubMed=17098252; DOI=10.1016/j.jmb.2006.10.039;
RA   Okuda M., Horikoshi M., Nishimura Y.;
RT   "Structural polymorphism of chromodomains in Chd1.";
RL   J. Mol. Biol. 365:1047-1062(2007).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 174-339, DOMAIN, INTERACTION WITH
RP   HISTONE H3K4ME3, AND MUTAGENESIS OF GLU-220.
RX   PubMed=17433364; DOI=10.1016/j.jmb.2007.03.024;
RA   Flanagan J.F., Blus B.J., Kim D., Clines K.L., Rastinejad F.,
RA   Khorasanizadeh S.;
RT   "Molecular implications of evolutionary differences in CHD double
RT   chromodomains.";
RL   J. Mol. Biol. 369:334-342(2007).
CC   -!- FUNCTION: ATP-dependent chromatin-remodeling factor which functions as
CC       substrate recognition component of the transcription regulatory histone
CC       acetylation (HAT) complexes SAGA and SLIK. It recognizes H3K4me. SAGA
CC       is involved in RNA polymerase II-dependent transcriptional regulation
CC       of approximately 10% of yeast genes. At the promoters, SAGA is required
CC       for recruitment of the basal transcription machinery. It influences RNA
CC       polymerase II transcriptional activity through different activities
CC       such as TBP interaction (SPT3, SPT8 and SPT20) and promoter
CC       selectivity, interaction with transcription activators (GCN5, ADA2,
CC       ADA3 and TRA1), and chromatin modification through histone acetylation
CC       (GCN5) and deubiquitination (UBP8). SAGA acetylates nucleosomal histone
CC       H3 to some extent (to form H3K9ac, H3K14ac, H3K18ac and H3K23ac). SAGA
CC       interacts with DNA via upstream activating sequences (UASs). SLIK is
CC       proposed to have partly overlapping functions with SAGA. It
CC       preferentially acetylates methylated histone H3, at least after
CC       activation at the GAL1-10 locus. Acts in opposition to the FACT complex
CC       in regulating polymerase II transcription. Also required for efficient
CC       transcription by RNA polymerase I, and more specifically the pol I
CC       transcription termination step. Negatively regulates DNA replication.
CC       Not only involved in transcription-related chromatin-remodeling, but
CC       also required to maintain a specific chromatin configuration across the
CC       genome. {ECO:0000269|PubMed:10026213, ECO:0000269|PubMed:10811623,
CC       ECO:0000269|PubMed:12682017, ECO:0000269|PubMed:14585955,
CC       ECO:0000269|PubMed:15647753, ECO:0000269|PubMed:16468993,
CC       ECO:0000269|PubMed:16606615, ECO:0000269|PubMed:17259992,
CC       ECO:0000269|PubMed:17620414, ECO:0000269|PubMed:17949749,
CC       ECO:0000269|PubMed:18245327}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10811623, ECO:0000269|PubMed:17949749};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.2 nM for ATP {ECO:0000269|PubMed:17949749};
CC   -!- SUBUNIT: Component of the 1.8 MDa SAGA complex, which consists of at
CC       least of TRA1, CHD1, SPT7, TAF5, ADA3, SGF73, SPT20/ADA5, SPT8, TAF12,
CC       TAF6, HFI1/ADA1, UBP8, GCN5, ADA2, SPT3, SGF29, TAF10, TAF9, SGF11 and
CC       SUS1. TAF5, TAF6, TAF9, TAF19, TAF12 and ADA1 seem to be present in 2
CC       copies. SAGA is built of 5 distinct domains with specialized functions.
CC       Domain I (containing TRA1) probably represents the activator
CC       interaction surface. Domain II (containing TAF5 and TAF6, and probably
CC       TAF9 and TAF10), domain III (containing GCN5, TAF10, SPT7, TAF5 and
CC       ADA1, and probably ADA2, ADA3 and TAF12), and domain IV (containing
CC       HFI1/ADA1 and TAF6, and probably TAF9) are believed to play primarily
CC       an architectural role. Domain III also harbors the HAT activity. Domain
CC       V (containing SPT3 and SPT20, and probably SPT8) represents the TBP-
CC       interacting module, which may be associated transiently with SAGA.
CC       Component of the SLIK complex, which consists of at least TRA1, CHD1,
CC       SPT7, TAF5, ADA3, SPT20, RTG2, TAF12, TAF6, HFI1, UBP8, GCN5, ADA2,
CC       SPT3, SGF29, TAF10 and TAF9. Interacts with RTF1, SPT5 and with the
CC       FACT subunits POB3 and SPT16. {ECO:0000269|PubMed:12242279,
CC       ECO:0000269|PubMed:12446794, ECO:0000269|PubMed:12682017,
CC       ECO:0000269|PubMed:15647753, ECO:0000269|PubMed:17433364,
CC       ECO:0000269|PubMed:17576814}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:12682017}.
CC   -!- DOMAIN: The 2 chromodomains are involved in the binding to the histone
CC       H3 methyllysine at position 4 (H3K4me3).
CC       {ECO:0000250|UniProtKB:O14646}.
CC   -!- DOMAIN: The CHD1 helical C-terminal domain (CHCT) binds DNA and
CC       nucleosomes. {ECO:0000250|UniProtKB:O14646}.
CC   -!- DISRUPTION PHENOTYPE: Decreased sensitivity to the cytotoxic effects of
CC       6-azauracil. {ECO:0000269|PubMed:9326634}.
CC   -!- MISCELLANEOUS: Present with 1620 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U18917; AAB64691.1; -; Genomic_DNA.
DR   EMBL; BK006939; DAA07826.1; -; Genomic_DNA.
DR   PIR; S30818; S30818.
DR   RefSeq; NP_011091.1; NM_001179054.1.
DR   PDB; 2DY7; NMR; -; A=172-252.
DR   PDB; 2DY8; NMR; -; A=279-347.
DR   PDB; 2H1E; X-ray; 2.20 A; A/B=174-339.
DR   PDB; 2XB0; X-ray; 2.00 A; X=1009-1274.
DR   PDB; 3MWY; X-ray; 3.70 A; W=142-939.
DR   PDB; 3TED; X-ray; 2.00 A; A=1006-1274.
DR   PDB; 5J70; X-ray; 2.96 A; A/B=1006-1274.
DR   PDB; 5O9G; EM; 4.80 A; W=1-1468.
DR   PDB; 6FTX; EM; 4.50 A; W=175-1269.
DR   PDB; 6G0L; EM; 4.50 A; M/W=1-1468.
DR   PDB; 7NKX; EM; 2.90 A; W=1-1468.
DR   PDB; 7TN2; EM; 2.30 A; W=118-1274.
DR   PDB; 9GD1; EM; 4.00 A; W=1-1468.
DR   PDB; 9GD2; EM; 4.20 A; S/T/W=1-1468.
DR   PDB; 9GD3; EM; 3.00 A; T/W=1-1468.
DR   PDBsum; 2DY7; -.
DR   PDBsum; 2DY8; -.
DR   PDBsum; 2H1E; -.
DR   PDBsum; 2XB0; -.
DR   PDBsum; 3MWY; -.
DR   PDBsum; 3TED; -.
DR   PDBsum; 5J70; -.
DR   PDBsum; 5O9G; -.
DR   PDBsum; 6FTX; -.
DR   PDBsum; 6G0L; -.
DR   PDBsum; 7NKX; -.
DR   PDBsum; 7TN2; -.
DR   PDBsum; 9GD1; -.
DR   PDBsum; 9GD2; -.
DR   PDBsum; 9GD3; -.
DR   AlphaFoldDB; P32657; -.
DR   EMDB; EMD-12449; -.
DR   EMDB; EMD-3765; -.
DR   EMDB; EMD-4336; -.
DR   EMDB; EMD-51241; -.
DR   EMDB; EMD-51244; -.
DR   EMDB; EMD-51247; -.
DR   SASBDB; P32657; -.
DR   SMR; P32657; -.
DR   BioGRID; 36917; 534.
DR   ComplexPortal; CPX-656; SAGA complex.
DR   ComplexPortal; CPX-675; SLIK (SAGA-like) complex.
DR   DIP; DIP-6362N; -.
DR   FunCoup; P32657; 1107.
DR   IntAct; P32657; 86.
DR   MINT; P32657; -.
DR   STRING; 4932.YER164W; -.
DR   ChEMBL; CHEMBL4662924; -.
DR   GlyGen; P32657; 4 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P32657; -.
DR   PaxDb; 4932-YER164W; -.
DR   PeptideAtlas; P32657; -.
DR   EnsemblFungi; YER164W_mRNA; YER164W; YER164W.
DR   GeneID; 856911; -.
DR   KEGG; sce:YER164W; -.
DR   AGR; SGD:S000000966; -.
DR   SGD; S000000966; CHD1.
DR   VEuPathDB; FungiDB:YER164W; -.
DR   eggNOG; KOG0384; Eukaryota.
DR   GeneTree; ENSGT00940000170579; -.
DR   HOGENOM; CLU_000315_29_2_1; -.
DR   InParanoid; P32657; -.
DR   OMA; WVQIRDD; -.
DR   OrthoDB; 5857104at2759; -.
DR   BioCyc; YEAST:G3O-30325-MONOMER; -.
DR   SABIO-RK; P32657; -.
DR   BioGRID-ORCS; 856911; 0 hits in 10 CRISPR screens.
DR   EvolutionaryTrace; P32657; -.
DR   PRO; PR:P32657; -.
DR   Proteomes; UP000002311; Chromosome V.
DR   RNAct; P32657; protein.
DR   GO; GO:0000785; C:chromatin; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0030874; C:nucleolar chromatin; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000124; C:SAGA complex; IDA:SGD.
DR   GO; GO:0035861; C:site of double-strand break; IDA:SGD.
DR   GO; GO:0046695; C:SLIK (SAGA-like) complex; IDA:SGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0008094; F:ATP-dependent activity, acting on DNA; IDA:SGD.
DR   GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; IDA:SGD.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:SGD.
DR   GO; GO:0003677; F:DNA binding; IDA:SGD.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0035064; F:methylated histone binding; IDA:SGD.
DR   GO; GO:0000182; F:rDNA binding; IDA:SGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:SGD.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:SGD.
DR   GO; GO:0000729; P:DNA double-strand break processing; IMP:SGD.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:SGD.
DR   GO; GO:2000104; P:negative regulation of DNA-templated DNA replication; IGI:SGD.
DR   GO; GO:0034728; P:nucleosome organization; IMP:SGD.
DR   GO; GO:1902275; P:regulation of chromatin organization; IMP:SGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:ComplexPortal.
DR   GO; GO:0001178; P:regulation of transcriptional start site selection at RNA polymerase II promoter; IGI:SGD.
DR   GO; GO:0007062; P:sister chromatid cohesion; IMP:SGD.
DR   GO; GO:0006363; P:termination of RNA polymerase I transcription; IGI:SGD.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; IMP:SGD.
DR   GO; GO:0006368; P:transcription elongation by RNA polymerase II; IGI:SGD.
DR   CDD; cd18665; CD1_tandem_CHD1_yeast_like; 1.
DR   CDD; cd18664; CD2_tandem_ScCHD1_like; 1.
DR   CDD; cd17993; DEXHc_CHD1_2; 1.
DR   CDD; cd11660; SANT_TRF; 1.
DR   CDD; cd18793; SF2_C_SNF; 1.
DR   FunFam; 2.40.50.40:FF:000038; Chromo domain-containing protein 1; 1.
DR   FunFam; 1.10.10.60:FF:000376; Chromodomain-helicase-DNA-binding protein 1; 1.
DR   FunFam; 3.40.50.10810:FF:000007; Chromodomain-helicase-DNA-binding protein 2 isoform 1; 1.
DR   FunFam; 3.40.50.300:FF:000130; Chromodomain-helicase-DNA-binding protein 2 isoform 1; 1.
DR   Gene3D; 2.40.50.40; -; 2.
DR   Gene3D; 6.10.140.1440; -; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 3.40.50.10810; Tandem AAA-ATPase domain; 1.
DR   InterPro; IPR041150; Cdh1_DBD.
DR   InterPro; IPR056302; CHD1-2/Hrp3_HTH.
DR   InterPro; IPR025260; CHD1-like_C.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR023779; Chromodomain_CS.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C-like.
DR   InterPro; IPR009057; Homeodomain-like_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR049730; SNF2/RAD54-like_C.
DR   InterPro; IPR000330; SNF2_N.
DR   PANTHER; PTHR45623:SF14; CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 1; 1.
DR   PANTHER; PTHR45623; CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 3-RELATED-RELATED; 1.
DR   Pfam; PF18196; Cdh1_DBD_1; 1.
DR   Pfam; PF13907; CHD1-like_C; 1.
DR   Pfam; PF00385; Chromo; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF23588; HTH_CHD1_Hrp3; 1.
DR   Pfam; PF00176; SNF2-rel_dom; 1.
DR   SMART; SM00298; CHROMO; 2.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM01176; DUF4208; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF54160; Chromo domain-like; 2.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS00598; CHROMO_1; 2.
DR   PROSITE; PS50013; CHROMO_2; 2.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Chromatin regulator; DNA-binding; Hydrolase;
KW   Isopeptide bond; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..1468
FT                   /note="Chromo domain-containing protein 1"
FT                   /id="PRO_0000080237"
FT   DOMAIN          195..257
FT                   /note="Chromo 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00053"
FT   DOMAIN          285..350
FT                   /note="Chromo 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00053"
FT   DOMAIN          388..562
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          699..860
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          21..176
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          974..1007
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1220..1247
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1270..1378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           513..516
FT                   /note="DEAH box"
FT   COMPBIAS        56..87
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        95..111
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        126..139
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        141..160
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1221..1234
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1287..1296
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1297..1310
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1354..1364
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         401..408
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17330950,
FT                   ECO:0007744|PubMed:18407956, ECO:0007744|PubMed:19779198"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         987
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         989
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         1336
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         1364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17287358"
FT   MOD_RES         1372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   CROSSLNK        1144
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:12872131"
FT   MUTAGEN         220
FT                   /note="E->L,W: No interaction with methylated histone H3
FT                   'K-4'."
FT                   /evidence="ECO:0000269|PubMed:15647753,
FT                   ECO:0000269|PubMed:17433364"
FT   MUTAGEN         222
FT                   /note="H->Y: Confers interaction with methylated histone H3
FT                   'K-4'."
FT                   /evidence="ECO:0000269|PubMed:15647753"
FT   MUTAGEN         314
FT                   /note="L->Y: No effect on interaction with methylated
FT                   histone H3 'K-4'."
FT                   /evidence="ECO:0000269|PubMed:15647753"
FT   MUTAGEN         316
FT                   /note="Y->E: Disrupts interaction with methylated histone
FT                   H3 'K-4'; abrogates histone acetylation activity of SLIK."
FT                   /evidence="ECO:0000269|PubMed:15647753"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          179..187
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   TURN            190..192
FT                   /evidence="ECO:0007829|PDB:2DY7"
FT   HELIX           193..196
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           204..210
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   STRAND          211..217
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           222..224
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   STRAND          226..228
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           230..233
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:2DY7"
FT   HELIX           239..249
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           251..258
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           264..283
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   STRAND          286..297
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   STRAND          299..301
FT                   /evidence="ECO:0007829|PDB:2DY8"
FT   STRAND          303..311
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   STRAND          316..318
FT                   /evidence="ECO:0007829|PDB:7NKX"
FT   STRAND          320..323
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           324..330
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           332..338
FT                   /evidence="ECO:0007829|PDB:2H1E"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           378..393
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          397..399
FT                   /evidence="ECO:0007829|PDB:9GD3"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:7NKX"
FT   HELIX           407..420
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          428..432
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           434..436
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           437..446
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          453..455
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           460..470
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          472..474
FT                   /evidence="ECO:0007829|PDB:9GD3"
FT   STRAND          482..484
FT                   /evidence="ECO:0007829|PDB:9GD3"
FT   STRAND          486..491
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           492..497
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           499..503
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          507..514
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           515..518
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           524..530
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          534..540
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          546..549
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           550..559
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   TURN            572..574
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           577..589
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           591..593
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   TURN            599..601
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          609..616
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           620..630
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           634..638
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          642..644
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           651..660
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           662..664
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           668..674
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           676..678
FT                   /evidence="ECO:0007829|PDB:9GD3"
FT   TURN            683..685
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           686..692
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           695..709
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          714..719
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           721..734
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          738..741
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           747..757
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          759..761
FT                   /evidence="ECO:0007829|PDB:7NKX"
FT   STRAND          766..772
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          785..788
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           795..802
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   TURN            803..805
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   STRAND          807..809
FT                   /evidence="ECO:0007829|PDB:7NKX"
FT   STRAND          814..821
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           826..843
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   TURN            844..846
FT                   /evidence="ECO:0007829|PDB:7TN2"
FT   HELIX           1012..1025
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1029..1031
FT                   /evidence="ECO:0007829|PDB:3TED"
FT   HELIX           1032..1037
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1046..1091
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   STRAND          1092..1094
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   STRAND          1096..1098
FT                   /evidence="ECO:0007829|PDB:3TED"
FT   STRAND          1101..1103
FT                   /evidence="ECO:0007829|PDB:3TED"
FT   HELIX           1104..1112
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   STRAND          1119..1122
FT                   /evidence="ECO:0007829|PDB:3TED"
FT   STRAND          1125..1129
FT                   /evidence="ECO:0007829|PDB:3TED"
FT   HELIX           1130..1150
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1155..1157
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   STRAND          1171..1173
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1177..1190
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1195..1200
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   TURN            1202..1204
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1207..1209
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   HELIX           1250..1264
FT                   /evidence="ECO:0007829|PDB:2XB0"
FT   TURN            1265..1268
FT                   /evidence="ECO:0007829|PDB:2XB0"
SQ   SEQUENCE   1468 AA;  168241 MW;  78BDB74C7FEC6BE5 CRC64;
     MAAKDISTEV LQNPELYGLR RSHRAAAHQQ NYFNDSDDED DEDNIKQSRR KRMTTIEDDE
     DEFEDEEGEE DSGEDEDEED FEEDDDYYGS PIKQNRSKPK SRTKSKSKSK PKSQSEKQST
     VKIPTRFSNR QNKTVNYNID YSDDDLLESE DDYGSEEALS EENVHEASAN PQPEDFHGID
     IVINHRLKTS LEEGKVLEKT VPDLNNCKEN YEFLIKWTDE SHLHNTWETY ESIGQVRGLK
     RLDNYCKQFI IEDQQVRLDP YVTAEDIEIM DMERERRLDE FEEFHVPERI IDSQRASLED
     GTSQLQYLVK WRRLNYDEAT WENATDIVKL APEQVKHFQN RENSKILPQY SSNYTSQRPR
     FEKLSVQPPF IKGGELRDFQ LTGINWMAFL WSKGDNGILA DEMGLGKTVQ TVAFISWLIF
     ARRQNGPHII VVPLSTMPAW LDTFEKWAPD LNCICYMGNQ KSRDTIREYE FYTNPRAKGK
     KTMKFNVLLT TYEYILKDRA ELGSIKWQFM AVDEAHRLKN AESSLYESLN SFKVANRMLI
     TGTPLQNNIK ELAALVNFLM PGRFTIDQEI DFENQDEEQE EYIHDLHRRI QPFILRRLKK
     DVEKSLPSKT ERILRVELSD VQTEYYKNIL TKNYSALTAG AKGGHFSLLN IMNELKKASN
     HPYLFDNAEE RVLQKFGDGK MTRENVLRGL IMSSGKMVLL DQLLTRLKKD GHRVLIFSQM
     VRMLDILGDY LSIKGINFQR LDGTVPSAQR RISIDHFNSP DSNDFVFLLS TRAGGLGINL
     MTADTVVIFD SDWNPQADLQ AMARAHRIGQ KNHVMVYRLV SKDTVEEEVL ERARKKMILE
     YAIISLGVTD GNKYTKKNEP NAGELSAILK FGAGNMFTAT DNQKKLEDLN LDDVLNHAED
     HVTTPDLGES HLGGEEFLKQ FEVTDYKADI DWDDIIPEEE LKKLQDEEQK RKDEEYVKEQ
     LEMMNRRDNA LKKIKNSVNG DGTAANSDSD DDSTSRSSRR RARANDMDSI GESEVRALYK
     AILKFGNLKE ILDELIADGT LPVKSFEKYG ETYDEMMEAA KDCVHEEEKN RKEILEKLEK
     HATAYRAKLK SGEIKAENQP KDNPLTRLSL KKREKKAVLF NFKGVKSLNA ESLLSRVEDL
     KYLKNLINSN YKDDPLKFSL GNNTPKPVQN WSSNWTKEED EKLLIGVFKY GYGSWTQIRD
     DPFLGITDKI FLNEVHNPVA KKSASSSDTT PTPSKKGKGI TGSSKKVPGA IHLGRRVDYL
     LSFLRGGLNT KSPSADIGSK KLPTGPSKKR QRKPANHSKS MTPEITSSEP ANGPPSKRMK
     ALPKGPAALI NNTRLSPNSP TPPLKSKVSR DNGTRQSSNP SSGSAHEKEY DSMDEEDCRH
     TMSAIRTSLK RLRRGGKSLD RKEWAKILKT ELTTIGNHIE SQKGSSRKAS PEKYRKHLWS
     YSANFWPADV KSTKLMAMYD KITESQKK
//
